Stockscreener 앱 받기
256.24
0.18%
-0.19
전일 마감가:
$256.43
열려 있는:
$256.34
하루 거래량:
124.09K
Relative Volume:
0.24
시가총액:
$9.90B
수익:
$1.24B
순이익/손실:
$42.23M
주가수익비율:
241.74
EPS:
1.06
순현금흐름:
$150.33M
1주 성능:
+0.59%
1개월 성능:
-4.12%
6개월 성능:
+7.46%
1년 성능:
+42.22%
1일 변동 폭
$254.06
$258.20
1주일 범위
$250.68
$258.20
52주 변동 폭
$148.00
$310.00
Penumbra Inc Stock (PEN) Company Profile
명칭
Penumbra Inc
전화
(510) 995-2486
주소
ONE PENUMBRA PLACE, ALAMEDA, CA
PEN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PEN
Penumbra Inc
|
255.98 | 9.90B | 1.24B | 42.23M | 150.33M | 1.06 |
|
ABT
Abbott Laboratories
|
135.63 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
107.13 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
394.20 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.16 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.25 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-14 | 개시 | BofA Securities | Buy |
| 2025-01-21 | 개시 | UBS | Buy |
| 2024-12-17 | 개시 | Oppenheimer | Outperform |
| 2024-12-11 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-09-18 | 개시 | Stifel | Buy |
| 2024-09-03 | 개시 | Leerink Partners | Outperform |
| 2024-07-31 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-07-31 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-02-23 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2023-09-06 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-03-29 | 다운그레이드 | Needham | Buy → Hold |
| 2023-01-30 | 개시 | Piper Sandler | Overweight |
| 2022-11-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-10-05 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-09-09 | 업그레이드 | Needham | Hold → Buy |
| 2022-07-18 | 개시 | RBC Capital Mkts | Outperform |
| 2022-04-19 | 개시 | Deutsche Bank | Buy |
| 2022-03-08 | 개시 | Needham | Hold |
| 2021-09-16 | 개시 | Truist | Buy |
| 2021-06-04 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-12-16 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-10-07 | 재개 | Canaccord Genuity | Buy |
| 2020-09-29 | 개시 | BTIG Research | Buy |
| 2020-09-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-06-13 | 재확인 | BofA/Merrill | Buy |
| 2019-05-30 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-05-21 | 개시 | William Blair | Outperform |
| 2018-10-29 | 재개 | BofA/Merrill | Buy |
| 2018-10-08 | 개시 | RBC Capital Mkts | Outperform |
| 2018-02-21 | 개시 | William Blair | Outperform |
| 2018-01-02 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2015-11-30 | 재확인 | Canaccord Genuity | Buy |
| 2015-10-13 | 개시 | Wells Fargo | Outperform |
모두보기
Penumbra Inc 주식(PEN)의 최신 뉴스
Insider Selling: Bridget O'Rourke Sells Shares of Penumbra Inc (PEN) - GuruFocus
Penumbra director O’Rourke sells $12988 in stock - Investing.com
Inquis, Penumbra advance thrombectomy treatments - BioWorld MedTech
Transcript : Penumbra, Inc. Presents at 2025 Truist Securities MedTech Conference, Jun-17-2025 10 - MarketScreener
Penumbra, Inc. Announces Completion of Enrollment for Landmark S - GuruFocus
Penumbra Completes Enrollment for STORM-PE Randomized Controlled Trial - Diagnostic and Interventional Cardiology
Penumbra completes enrollment in pulmonary embolism trial - MassDevice
Penumbra's Revolutionary PE Treatment Trial Hits 100-Patient Mark, Results Could Transform Blood Clot Care - Stock Titan
Clot Management Devices Market Set to Witness Significant - openPR.com
PEN Stock Rises Following the Launch of Ruby XL System - MSN
RSI Alert: Penumbra (PEN) Now Oversold - Nasdaq
Zacks Industry Outlook Penumbra, Integer and AngioDynamics - Yahoo Finance
Penumbra Introduces the Ruby XL System – the Longest, Largest, and Softest Coil on the Market for Vascular Embolization - HMP Global Learning Network
Insider Sell: Johanna Roberts Sells 600 Shares of Penumbra Inc (PEN) - GuruFocus
Penumbra Introduces the Ruby® XL Systemthe Longest, Largest, and Softest Coil on the Market for Vascular Embolization - StreetInsider
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Continues Penumbra (PEN) Fraud Investigation In Light Of Company’s Admissions, Encourages Investors to Contact its Attorneys Now - ACCESS Newswire
Penumbra Introduces the Ruby® Xl System - marketscreener.com
PEN Unveils Ruby XL System with FDA Clearance | PEN Stock News - GuruFocus
Penumbra Launches US FDA-Cleared Ruby XL Coil System - marketscreener.com
Penumbra announces FDA approval, launch of Ruby XL System - TipRanks
Just Launched: Penumbra's New Ruby XL System Delivers 40mm Coils Through Standard CathetersLargest in Market - Stock Titan
Penumbra’s EVP Johanna Roberts sells $154,903 in stock By Investing.com - Investing.com Canada
Penumbra’s EVP Johanna Roberts sells $154,903 in stock - Investing.com Australia
Transcript : Penumbra, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 09 - marketscreener.com
Transcript : Penumbra, Inc. Presents at 45th Annual William Blair Growth Stock Conference, Jun-03-2025 02 - marketscreener.com
Penumbra Inc (PEN) Shares Gap Down to $257.585 on Jun 2 - GuruFocus
Penumbra Insider Sold Shares Worth $4,366,920, According to a Recent SEC Filing - marketscreener.com
3 Reasons to Sell PEN and 1 Stock to Buy Instead - Yahoo Finance
Penumbra CEO Adam Elsesser sells $4.37 million in stock By Investing.com - Investing.com India
Penumbra CEO Adam Elsesser sells $4.37 million in stock - Investing.com Australia
Penumbra Amends Incorporation Certificate After Stockholder Vote - TipRanks
Managing Acute Limb Ischemia With Penumbra Lightning Bolt™ Technology - HMP Global Learning Network
Why Investors Shouldn't Be Surprised By Penumbra, Inc.'s (NYSE:PEN) P/S - simplywall.st
Why Is Penumbra (PEN) Down 10.6% Since Last Earnings Report? - Yahoo Finance
Penumbra (NYSE:PEN) shareholders are still up 88% over 3 years despite pulling back 3.1% in the past week - Yahoo Finance
Penumbra, Inc. to Present at Upcoming Investor Conferences - Eastern Progress
Penumbra Rallies 35.9% in a Year: What's Driving the Stock? - sharewise
Penumbra, Inc. to Present at Upcoming Investor Conferences | PEN Stock News - GuruFocus
Blend Extra: Stroke Awareness Month And How Quick Action Can Save Lives - TMJ4 News
Insider Sell Alert: Bridget O'Rourke Sells Shares of Penumbra Inc (PEN) - GuruFocus
Here's Why Penumbra (PEN) is a Strong Momentum Stock - Yahoo Finance
Penumbra EVP Johanna Roberts sells $268,697 in stock By Investing.com - Investing.com Nigeria
Penumbra Inc (PEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Penumbra Inc 주식 (PEN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Elsesser Adam | CEO and President |
Jun 25 '25 |
Option Exercise |
30.00 |
27,976 |
839,280 |
138,331 |
| Elsesser Adam | CEO and President |
Jun 25 '25 |
Sale |
253.40 |
15,890 |
4,026,589 |
122,441 |
0.19%
0.75%
자본화:
|
볼륨(24시간):